Solute carrier family 25 member 19 (SLC25A19) is a transporter protein of thiamine pyrophosphate across cellular membranes, which is needed as a cofactor for multiple metabolic enzymes and is ...

The incidence of gastrointestinal cancers varies across Asian American, Native Hawaiian and other Pacific Islander communities, according to a study published March 15 in the journal Gastro Hep ...

In early-stage HCC patients (BCLC 0 and A), CP mRNA was elevated in 67.9% of cases, outperforming AFP, which detected only 46 ...

The risk of dying from the most common form of primary liver cancer is about 30% higher for patients with low household ...

There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to ...

The Italian study showed that patients with HCC resulting from viral infections or fatty liver had significantly higher ...

The clinical trial will include nearly 150 patients with advanced hepatocellular carcinoma that expresses glypican-3.

HCC occurred in 1.27% of patients with PBC, which is lower than the recommended threshold for cost-effective surveillance.

The appearance of vulvar cancer will vary depending on the type. In general, signs of vulvar cancer can include moles, lumps, or bumps on the vulva, flakiness or thickening of the skin in that area, ...

for the first-line treatment of adults with recurrent or metastatic nonkeratinizing nasopharyngeal carcinoma (NPC); or as a single agent, for the treatment of adults with metastatic ...

Approval of penpulimab-kcqx marks the company’s US regulatory debut and introduces a new immunotherapy option for advanced nasopharyngeal carcinoma. The FDA has approved Akeso’s penpulimab-kcqx, a ...

The FDA has approved penpulimab-kcqx with chemotherapy and as a single agent for some patients with nasopharyngeal carcinoma. The United States Food and Drug Administration (FDA) has approved ...